©2025 Stanford Medicine
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Recruiting
I'm InterestedTrial ID: NCT01034033
Purpose
The purpose of this study is to try to understand the biology of development of breast, ovarian, fallopian tube, peritoneal or endometrial cancer from persons at high genetic risk for these diseases. The influence of environmental factors on cancer development in individuals and families will be studied. The efficacy of treatments for these diseases will be evaluated.
Official Title
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Stanford Investigator(s)
James Ford
Professor of Medicine (Oncology) and of Genetics and, by courtesy, of Pediatrics
Allison W. Kurian, M.D., M.Sc.
Professor of Medicine (Oncology) and of Epidemiology and Population Health
Jonathan S. Berek, MD, MMSc
Laurie Kraus Lacob Professor
Jafi Alyssa Lipson
Clinical Associate Professor, Radiology
Eligibility
Inclusion Criteria:
I. Women who have a high risk of developing breast or ovarian cancer due to a known germline mutation in the BRCA1/2, PTEN, CDH1, or TP53 cancer susceptibility genes, or due to strong family history of either breast or ovarian cancer, in the absence of known cancer susceptibility gene mutation.
II. Women who are approaching surgery for resection of a pelvic mass, which is considered suspicious for neoplasia by radiologic or clinical criteria; such women may or may not also meet criteria for inclusion in group I.
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Meredith Mills
650-724-5223